Continuum Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,267
| Closed | -$366K | – | 1186 |
|
|
2025
Q1 | $366K | Sell |
5,267
-95
| -2% | -$6.6K | 0.05% | 287 |
|
|
2024
Q4 | $461K | Buy |
5,362
+40
| +0.8% | +$3.44K | 0.06% | 245 |
|
|
2024
Q3 | $561K | Buy |
5,322
+1,261
| +31% | +$133K | 0.07% | 231 |
|
|
2024
Q2 | $580K | Buy |
4,061
+37
| +0.9% | +$5.28K | 0.08% | 208 |
|
|
2024
Q1 | $518K | Buy |
4,024
+867
| +27% | +$112K | 0.08% | 221 |
|
|
2023
Q4 | $327K | Sell |
3,157
-89
| -3% | -$9.21K | 0.05% | 354 |
|
|
2023
Q3 | $295K | Buy |
3,246
+730
| +29% | +$66.4K | 0.05% | 370 |
|
|
2023
Q2 | $204K | Buy |
+2,516
| New | +$204K | 0.03% | 430 |
|